Differences Between Neurological Disorders and Psychiatric Disorders
“Neuropathy” specifically refers to diseases of the peripheral nerves—formerly termed “neuritis”—and represents a group of organic disorders affecting the peripheral nervous system. Based on anatomical location and functional roles, the nervous system is divided into the central nervous system (CNS) and the peripheral nervous system (PNS). Neuropathy denotes the pathological features resulting from structural damage to peripheral nerves, characterized primarily by organic lesions in the peripheral nerves. In non-professional contexts, “neuropathy” is often mistakenly conflated with “psychosis.”

Distinguishing Neuropathy from Psychosis
Neuropathy and psychosis are two distinct categories of disease. Psychosis refers to psychiatric disorders characterized by marked emotional lability, irritability, and agitation. Neuropathy, by contrast, involves pathological changes in the peripheral nervous system—conditions such as cerebral infarction, encephalitis, epilepsy, or brain tumors may be present. Neuropathy typically arises secondary to intracranial infection or toxic exposure, commonly manifesting as headache, dizziness, and sleep disturbances.
Neuropathy encompasses disorders of the nervous system that may present with symptoms including numbness and limb paralysis; clinical management relies predominantly on pharmacotherapy. The etiologies, clinical manifestations, and treatment approaches for neuropathy and psychosis differ significantly. Psychosis primarily reflects dysfunction of higher brain functions, clinically presenting as varying degrees of impairment in cognition, emotion, volition, and behavior—often attributable to complex interactions among biological, psychological, and socio-environmental factors. It is thus classified as a functional disorder. These two conditions represent fundamentally different disease entities and must not be confused.

How to Prevent Relapse of Psychosis
1. Promote public education on mental health care, enabling family members and the broader community to recognize early warning signs of relapse, implement preventive strategies, and know appropriate actions to take during recurrence.
2. Patients must adhere strictly to prescribed maintenance-dose medications; some individuals require lifelong pharmacotherapy without interruption.
3. Minimize or avoid exposing patients to adverse psychosocial stressors; ensure a supportive and restful environment; provide empathetic care to help maintain emotional well-being.
4. Should early signs of relapse emerge—such as insomnia, emotional instability, refusal to seek medical care or take medication, apathy, social withdrawal, excessive suspicion, or symptoms resembling neurosis—patients should promptly undergo clinical reassessment and dosage adjustment to rapidly stabilize their condition and prevent full relapse.

The above outlines key distinctions between neuropathy and psychosis. We hope this information proves helpful.